23
Participants
Start Date
January 10, 2019
Primary Completion Date
July 3, 2020
Study Completion Date
July 3, 2020
DEXCOM G6 RT-CGM
CGM is a way to measure glucose levels in real-time. A tiny electrode called a glucose sensor is inserted under the skin to measure glucose levels in tissue fluid. A small plastic piece of tube remains inserted in the skin. It is connected to a transmitter that sits on top of the skin. It is approved for use on the abdomen for 10 days. It either records the sugars downloaded in the clinic (blinded part of the study) or it sends the information via wireless radio frequency to a monitoring/ display device or to a cellular phone so participants can see data. DEXCOM G6 is FDA approved for use in patients with diabetes and will be used in accordance with instructions as approved for diabetes.
GWU Medical Faculty Associates, Washington D.C.
DexCom, Inc.
INDUSTRY
Nicole Ehrhardt, MD
OTHER